<DOC>
	<DOCNO>NCT00555074</DOCNO>
	<brief_summary>The purpose study compare efficacy safety sodium tungstate versus placebo patient obesity ( grade I II ) .</brief_summary>
	<brief_title>Sodium Tungstate Obesity</brief_title>
	<detailed_description />
	<mesh_term>Obesity</mesh_term>
	<criteria>BMI : 3039.9 Kg/m2 In case male gender , 18 65 year old In case female gender , diagnosis menopause Body weight change &lt; 3 kg last 3 month In case arterial hypertension dyslipemia , change dose last 2 month Exclusion criterion : In case female gender , absence menopause Evidence secondary cause obesity Diabetes , type II Concomitant treatment drug affect body weight Previous surgical intervention obesity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2008</verification_date>
</DOC>